{"id":"https://openalex.org/W4361944731","doi":"https://doi.org/10.1158/1078-0432.c.6522836","title":"Data from Ganitumab (AMG 479) Inhibits IGF-II\u2013Dependent Ovarian Cancer Growth and Potentiates Platinum-Based Chemotherapy","display_name":"Data from Ganitumab (AMG 479) Inhibits IGF-II\u2013Dependent Ovarian Cancer Growth and Potentiates Platinum-Based Chemotherapy","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361944731","doi":"https://doi.org/10.1158/1078-0432.c.6522836"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6522836","doi":"https://doi.org/10.1158/1078-0432.c.6522836","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6522836","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.c.6522836","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019770407","display_name":"Pedro J. Beltran","orcid":"https://orcid.org/0000-0002-4103-6494","observed_orcids":["https://orcid.org/0000-0002-4103-6494"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pedro J. Beltran","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111671838","display_name":"Frank J. Calzone","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frank J. Calzone","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029171347","display_name":"Petia Mitchell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Petia Mitchell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082564288","display_name":"Young-Ah Chung","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Young-Ah Chung","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062139061","display_name":"Elaina E Cajulis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elaina Cajulis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032290146","display_name":"Gordon E. Moody","orcid":"https://orcid.org/0009-0001-6949-6855","observed_orcids":["https://orcid.org/0009-0001-6949-6855"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gordon Moody","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021750238","display_name":"Brian Belmontes","orcid":"https://orcid.org/0000-0003-0141-1007","observed_orcids":["https://orcid.org/0000-0003-0141-1007"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian Belmontes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047012821","display_name":"Chi-Ming Li","orcid":"https://orcid.org/0000-0002-2740-5652","observed_orcids":["https://orcid.org/0000-0002-2740-5652"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chi-Ming Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010252578","display_name":"Steven L. Vonderfecht","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven Vonderfecht","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006560755","display_name":"Victor E. Velculescu","orcid":"https://orcid.org/0000-0003-1195-438X","observed_orcids":["https://orcid.org/0000-0003-1195-438X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Victor E. Velculescu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112514248","display_name":"Guorong Yang","orcid":"https://orcid.org/0009-0001-7444-921X","observed_orcids":["https://orcid.org/0009-0001-7444-921X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guorong Yang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Jingwei Qi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jingwei Qi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015491002","display_name":"Dennis J. Slamon","orcid":"https://orcid.org/0000-0002-6330-498X","observed_orcids":["https://orcid.org/0000-0002-6330-498X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dennis J. Slamon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5062837404","display_name":"Gottfried E. Konecny","orcid":"https://orcid.org/0000-0001-6083-657X","observed_orcids":["https://orcid.org/0000-0001-6083-657X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gottfried E. Konecny","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.7675999999046326,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.7675999999046326,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.2272000014781952,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10390","display_name":"Ovarian function and disorders","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ganitumab","display_name":"ganitumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/igf-ii","display_name":"insulin-like growth factor II","score":0.7680000066757202},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.7720000147819519},{"id":"https://openalex.org/keywords/igf-1-receptor","display_name":"IGF-1 receptor","score":0.7770000100135803},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.746999979019165},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.7789999842643738},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9039999842643738},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.996999979019165},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.7730000019073486},{"id":"https://openalex.org/keywords/pten-loss","display_name":"PTEN loss","score":0.9399999976158142},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.9739999771118164},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.7649999856948853},{"id":"https://openalex.org/keywords/patient-selection","display_name":"patient selection","score":0.5049999952316284}],"concepts":[{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5882325768470764},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.5536028742790222},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.4924720227718353},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.4891386330127716},{"id":"https://openalex.org/C2780689927","wikidata":"https://www.wikidata.org/wiki/Q24766801","display_name":"Insulin-like growth factor","level":4,"score":0.48696503043174744},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.46710577607154846},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.43371888995170593},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4321577250957489},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.42288583517074585},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.42268988490104675},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.412311315536499},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.383559912443161},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.38333600759506226},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.34444838762283325},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3428725004196167},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.33624762296676636},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32842952013015747},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30533918738365173},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2587569057941437},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.17978662252426147},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06277626752853394},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.c.6522836","doi":"https://doi.org/10.1158/1078-0432.c.6522836","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6522836","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.c.6522836.v1","doi":"https://doi.org/10.1158/1078-0432.c.6522836.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6522836.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6522836","doi":"https://doi.org/10.1158/1078-0432.c.6522836","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6522836","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2094145539","https://openalex.org/W2600744694","https://openalex.org/W4318262272","https://openalex.org/W3206717762","https://openalex.org/W2324043560","https://openalex.org/W2605227591","https://openalex.org/W2127812467","https://openalex.org/W4361243655","https://openalex.org/W2772682581","https://openalex.org/W3158157573"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Insulin-like":[2],"growth":[3,115],"factor":[4],"1":[5],"receptor":[6,158],"(IGF-IR)":[7],"has":[8],"been":[9],"implicated":[10],"in":[11,49,74,77,108,111,160,163,178,188,193,210,216],"the":[12,30,36,184],"pathogenesis":[13],"of":[14,33,38,45,54,63,186,223,226],"ovarian":[15,39,57,81,121,189,219,237],"cancer.":[16,40,220],"Ganitumab":[17,145],"is":[18],"an":[19],"investigational,":[20],"fully":[21],"human":[22],"monoclonal":[23],"antibody":[24],"against":[25,51],"IGF-IR.":[26],"Here,":[27],"we":[28],"explore":[29],"therapeutic":[31],"potential":[32],"ganitumab":[34,46,64,100,173,181,204],"for":[35,172],"treatment":[37],"Experimental":[41],"Design:":[42],"The":[43,61],"effects":[44],"were":[47,106,131,170],"tested":[48],"vitro":[50,75,109,161],"a":[52,199,206],"panel":[53],"23":[55],"established":[56],"cancer":[58,82,122,190,238],"cell":[59,123],"lines.":[60,124],"ability":[62],"to":[65,136,143,202,243],"inhibit":[66],"IGF-I\u2013,":[67,150],"IGF-II\u2013,":[68,151],"and":[69,76,94,101,110,127,138,149,152,155,162,166,174,214],"insulin-mediated":[70],"signaling":[71,159],"was":[72],"examined":[73],"tumor":[78,224],"xenografts":[79],"using":[80],"models":[83,192],"displaying":[84],"IGF-IR/PI3K/AKT":[85],"pathway":[86],"activation":[87],"by":[88],"two":[89],"distinct":[90],"mechanisms,":[91],"PTEN":[92,139,230],"loss":[93],"IGF-II":[95,125],"overexpression.":[96],"Drug":[97],"interactions":[98,169],"between":[99],"cisplatin,":[102],"carboplatin,":[103],"or":[104,176,209,229],"paclitaxel":[105,177,215],"studied":[107],"vivo.":[112,164,194],"Results:In":[113],"vitro,":[114],"inhibition":[116],"varied":[117],"significantly":[118,182],"among":[119],"individual":[120],"mRNA":[126],"phospho\u2013IGF-IR":[128],"protein":[129],"expression":[130,225],"quantitatively":[132],"correlated":[133],"with":[134,212,218,236],"response":[135],"ganitumab,":[137],"mutations":[140],"conferred":[141],"resistance":[142],"ganitumab.":[144,246],"potently":[146],"inhibited":[147],"baseline":[148],"insulin-induced":[153],"IGF-IR":[154],"IGF-IR/insulin":[156],"hybrid":[157],"Synergistic":[165],"additive":[167],"drug":[168],"seen":[171],"carboplatin":[175],"vitro.":[179],"Furthermore,":[180],"increased":[183],"efficacy":[185],"cisplatin":[187],"xenograft":[191],"Conclusions:":[195],"These":[196],"observations":[197],"provide":[198],"biologic":[200],"rationale":[201],"test":[203],"as":[205],"single":[207],"agent":[208],"combination":[211],"carboplatin/cisplatin":[213],"patients":[217,235],"Moreover,":[221],"assessment":[222],"IGF-II,":[227],"phospho\u2013IGF-IR,":[228],"status":[231],"may":[232],"help":[233],"select":[234],"who":[239],"are":[240],"most":[241],"likely":[242],"benefit":[244],"from":[245],"Clin":[247],"Cancer":[248],"Res;":[249],"20(11);":[250],"2947\u201358.":[251],"\u00a92014":[252],"AACR.":[253]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}